Clinical trial enrollment remains one of the most persistent challenges in medical research. Sponsors and CROs may identify promising study locations, launch recruitment campaigns, and invest in outreach programs, yet many studies still struggle to connect with qualified participants.
One reason is that traditional research models often operate separately from the environments where patients routinely receive care. Potential participants may never hear about relevant studies, while physicians may lack the infrastructure, time, or research support needed to introduce clinical trials during regular patient visits.
Embedded research models address this gap by integrating clinical research directly into community healthcare settings. Rather than asking patients and physicians to navigate a separate research ecosystem, these models make study participation part of an existing care journey.
This approach can expand patient access, strengthen clinical trial enrollment, reduce participation barriers, and generate real-world data that more accurately reflects routine clinical practice.
What Are Embedded Research Models?
Embedded research models integrate clinical trial operations into established healthcare practices, physician groups, and community care networks.
Instead of creating a standalone research site that must build a patient population from the ground up, the embedded model brings the necessary research infrastructure into a practice that already has physicians, clinical workflows, and trusted patient relationships.
Depending on the study and healthcare setting, embedded support may include:
- Study feasibility and patient population analysis
- Site activation and regulatory support
- Patient identification and prescreening
- Multilingual recruitment campaigns
- Appointment scheduling and reminders
- Clinical research staff and operational oversight
- Data collection and quality management
- Patient follow-up and retention support
The objective is not to disrupt routine care. It is to create a structured connection between clinical care and medical research.
Why Traditional Clinical Trial Enrollment Falls Short
Enrollment challenges are rarely caused by a single issue. They typically result from multiple operational and patient-level barriers.
Qualified patients may live far from conventional research centers. Others may not recognize clinical trials as a possible care option. Physicians may know that a patient could benefit from learning about a study but may not have the staff or processes required to support enrollment.
Patients can also encounter complex study information, transportation concerns, unfamiliar research personnel, language barriers, and scheduling difficulties. Each additional step creates another opportunity for a potential participant to disengage.
Traditional recruitment campaigns may generate awareness, but awareness alone does not guarantee enrollment. A lead must still be evaluated, contacted, educated, scheduled, screened, and supported throughout the process.
Embedded research models reduce these gaps by connecting recruitment with the patient’s existing healthcare experience.
How Embedded Research Models Improve Clinical Trial Enrollment
1. They connect studies with existing patient populations
Community healthcare practices already serve patients with diagnosed conditions, documented treatment histories, and ongoing relationships with physicians.
Embedding research within these environments allows study teams to evaluate opportunities based on actual patient populations rather than relying only on general market estimates. This can improve feasibility decisions and help sponsors identify locations with stronger enrollment potential.
Healthcare analytics can further support this process by examining de-identified patient population trends, therapeutic areas, diagnoses, and other relevant characteristics before a study is activated.
2. They introduce research through trusted care relationships
Trust plays an important role in whether patients feel comfortable considering a clinical trial.
Patients may be more receptive to learning about research when the opportunity is presented through a physician or care team they already know. The study becomes connected to an established healthcare relationship rather than appearing as an unfamiliar external offer.
The physician remains focused on the patient’s care, while a specialized research team manages study education, screening, consent, scheduling, documentation, and follow-up.
This collaboration gives patients access to research opportunities without requiring the medical practice to build an entire research department independently.
3. They create a more guided patient journey
Generating patient interest is only the beginning of clinical trial enrollment.
Potential participants need clear communication throughout the journey. They may need help understanding the study, determining whether they meet preliminary criteria, scheduling visits, preparing documentation, and remembering upcoming appointments.
Embedded research models can create a structured process that includes:
- Initial outreach in the patient’s preferred language
- Prescreening based on study criteria
- Clear explanations of the next steps
- Appointment scheduling
- Visit reminders
- Follow-up after missed or incomplete appointments
- Continued communication throughout participation
A better-supported journey can reduce confusion and prevent qualified candidates from being lost between initial interest and formal screening.
4. They reduce geographic and logistical barriers
Research participation has traditionally been concentrated around large academic institutions and major medical centers. This can limit access for patients who receive care in community settings.
By integrating trials into local practices, embedded research models can bring studies closer to where patients live and already receive care. This may reduce travel requirements, make study visits easier to coordinate, and expand research access to populations that have historically had fewer opportunities to participate.
For sponsors and CROs, this creates a broader and potentially more representative enrollment base.
5. They support retention after enrollment
Enrollment performance should not be measured only by how many patients sign a consent form. Participants must remain engaged through the study’s required visits and procedures.
Embedded teams can support retention through consistent communication, appointment reminders, visit coordination, and rapid responses to patient questions.
Because research is integrated into a familiar care environment, participants may also experience greater continuity between their medical care and study participation.
How Embedded Research Strengthens Real-World Data
Embedded research models can improve more than recruitment. They can also strengthen the relevance of real-world data by capturing evidence within community healthcare environments.
Traditional clinical trials are designed to answer specific scientific questions under controlled conditions. However, sponsors, regulators, healthcare organizations, and commercial teams increasingly need to understand how treatments perform across broader patient populations and routine care settings.
Community-based research can help produce evidence that reflects:
- More diverse patient demographics
- Different care environments
- Existing treatment patterns
- Common comorbidities
- Variations in healthcare access
- Real-world patient behavior and adherence
When research is embedded into clinical practice, study data can be interpreted alongside a clearer understanding of the patient’s broader care journey.
This does not eliminate the need for controlled clinical research. Instead, it can complement traditional trial data and support a more complete evidence strategy.
The Role of Healthcare Analytics and Artificial Intelligence
Technology can make embedded research models more scalable, but it must be applied responsibly.
Healthcare analytics can help research teams evaluate patient populations, identify enrollment trends, monitor site performance, and determine where patients are disengaging from the recruitment process.
Artificial intelligence in healthcare may also support activities such as:
- Reviewing structured patient information against study criteria
- Prioritizing potential candidates for human review
- Forecasting enrollment risks
- Identifying operational bottlenecks
- Supporting patient communication workflows
- Monitoring study performance across multiple locations
However, artificial intelligence should support clinical and operational decision-making rather than replace physician judgment, informed consent, or human oversight.
Data privacy, validation, transparency, and regulatory compliance must remain central to any technology-enabled research strategy.
What Sponsors and CROs Should Evaluate
Not every embedded research partner offers the same level of support. Sponsors and CROs should evaluate whether a potential partner can provide both patient access and consistent study execution.
Important considerations include:
- Access to relevant community patient populations
- Experience integrating research into clinical workflows
- Centralized regulatory and operational support
- Reliable prescreening and scheduling processes
- Multilingual patient engagement capabilities
- Research-trained clinical staff
- Quality management and data oversight
- Clear site-level performance reporting
- Scalable technology and healthcare analytics
- Patient retention and follow-up processes
The most effective embedded research models combine local physician relationships with centralized infrastructure. This allows studies to maintain community-level patient access while applying consistent processes across multiple locations.
Building a More Connected Research Ecosystem
Improving clinical trial enrollment requires more than increasing advertising spend or opening additional standalone sites. It requires reducing the separation between research, healthcare providers, and the patients who may qualify.
Embedded research models create a more connected approach by bringing clinical trials into routine community care. They help sponsors reach established patient populations, give physicians the infrastructure needed to offer research opportunities, and provide participants with a more familiar and supported experience.
For pharmaceutical sponsors and CROs, the result can be a stronger enrollment strategy, better patient retention, and real-world data that more accurately represents the communities treatments are intended to serve.
Bring Clinical Research Closer to Patients
FOMAT integrates clinical trials into community healthcare settings through centralized research operations, patient engagement, and site-level execution.
Connect with FOMAT to explore an embedded research strategy for your next clinical trial.